R & D OF FUNCTIONALISED DRY SOAP SPONGES (Q3180875): Difference between revisions
Jump to navigation
Jump to search
(Created claim: summary (P836): Jalsosa is a small textile company of family origin that was born in 1985. Jalsosa’s activity is the manufacture of nonwovens for the personal hygiene market. The company also markets other products for that market. Jalsosa has its productive facilities in the town of Pinos Puente, in the province of Granada. In these facilities, it mainly opens, blends, carding, stripping and thermofusion bound the fabrics, as well as the impregnation, cutting...) |
(Changed label, description and/or aliases in en: translated_label) |
||
| label / en | label / en | ||
R & D OF FUNCTIONALISED DRY SOAP SPONGES | |||
Revision as of 19:28, 12 October 2021
Project Q3180875 in Spain
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | R & D OF FUNCTIONALISED DRY SOAP SPONGES |
Project Q3180875 in Spain |
Statements
179,659.2 Euro
0 references
224,574.0 Euro
0 references
80.0 percent
0 references
9 November 2020
0 references
30 April 2022
0 references
JALSOSA, S.L.
0 references
37°15'5.76"N, 3°44'57.37"W
0 references
18158
0 references
JALSOSA es una pequeña empresa textil de origen familiar que nace en 1985. La actividad de JALSOSA es la fabricación de telas sin tejer con destino al mercado de la higiene personal. Asimismo, la empresa comercializa otros productos para dicho mercado. JALSOSA tiene sus instalaciones productivas en la localidad de Pinos Puente, en la provincia de Granada. En dichas instalaciones realiza, principalmente, la apertura, mezcla, cardado, napado y consolidado por termofusión de las telas, así como la impregnación, corte y envasado de los productos finales._x000D_ En este proyecto, JALSOSA pretende el desarrollo de una nueva esponja jabonosa biocida seca, de un solo uso y utilización principal en hospitales, que proporcione una desinfección completa de pacientes y personal sanitario. Al margen de su funcionalidad habitual (limpieza e higiene), se le añade la funcionalidad biocida, capaz de combatir la presencia de bacterias y virus en la piel, como es el caso del coronavirus SAR-CoV-2, tan nombrado últimamente. Atiende, por tanto, a la necesidad de reducir la contaminación cruzada por coronavirus SARS-CoV-2 entre paciente y personal sanitario y la transmisión de otras enfermedades nosocomiales. Aunque sus aplicaciones son muy amplias, el nuevo producto a desarrollar se considera un producto sanitario pensado especialmente para facilitar y maximizar la higiene de pacientes ingresados en la UCI, en los que se considera primordial prevenir y/o controlar el contagio de enfermedades de transmisión vírica o bacteriana. La principal dificultad que presenta este proyecto es conseguir un proceso de fabricación de la esponja que permita alcanzar la función biocida con la efectividad propuesta y un alto nivel de regularidad en toda su superficie. Para ello se necesita una dosificación muy precisa del biocida a aplicar, tanto en la cantidad, como en la distribución sobre el soporte textil. También serán factores importantes, la compatibilidad con el soporte textil y el gel utilizado. (Spanish)
0 references
Jalsosa is a small textile company of family origin that was born in 1985. Jalsosa’s activity is the manufacture of nonwovens for the personal hygiene market. The company also markets other products for that market. Jalsosa has its productive facilities in the town of Pinos Puente, in the province of Granada. In these facilities, it mainly opens, blends, carding, stripping and thermofusion bound the fabrics, as well as the impregnation, cutting and packaging of the final products._x000D_ In this project, Jalsosa aims to develop a new dry biocidal soap sponge, for single use and main use in hospitals, providing complete disinfection of patients and healthcare personnel. Apart from its usual functionality (cleaning and hygiene), it is added the biocidal functionality, able to combat the presence of bacteria and viruses in the skin, as is the case with the coronavirus SAR-CoV-2, so recently named. It therefore addresses the need to reduce cross-contamination by coronavirus SARS-CoV-2 between patients and healthcare workers and the transmission of other nosocomial diseases. Although its applications are very broad, the new product to be developed is considered a medical device specially designed to facilitate and maximise the hygiene of patients admitted to the ICU, in which it is considered essential to prevent or control the transmission of viral or bacterial diseases. The main difficulty this project presents is to achieve a sponge manufacturing process that allows achieving the biocidal function with the proposed effectiveness and a high level of regularity throughout its surface. This requires a very precise dosage of the biocidal product to be applied, both in quantity and distribution on the textile backing. Compatibility with the textile support and the gel used will also be important factors. (English)
12 October 2021
0 references
Pinos Puente
0 references
Identifiers
IDI-20210211
0 references